Journal of pain and symptom management
-
J Pain Symptom Manage · Jun 2015
Multicenter Study Comparative StudyNeuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients With Colorectal vs. Breast, Lung, or Prostate Cancer: Results From a Prospective Multicenter Study.
Few studies have examined the prevalence and severity of treatment-induced neuropathic symptoms in patients across different cancer types. ⋯ Patients with CRC experience significantly higher rates of N/T but comparable neuropathic pain, relative to patients with other cancers. Awareness of the prevalence and severity of neuropathic symptoms and their associated risk factors in this patient population is critical for both clinicians and patients.
-
J Pain Symptom Manage · Jun 2015
Randomized Controlled Trial Multicenter StudyFeasibility of Conducting a Palliative Care Randomized Controlled Trial in Children With Advanced Cancer: Assessment of the PediQUEST Study.
Pediatric palliative care randomized controlled trials (PPC-RCTs) are uncommon. ⋯ A PPC-RCT in children with advanced cancer was feasible, post-inclusion retention adequate; many families participated for altruistic reasons. Strategies that may further PPC-RCT feasibility include: increasing target population through large multicenter studies, approaching sicker patients, preventing exclusion of certain patient groups, and improving data collection at end of life.
-
J Pain Symptom Manage · Jun 2015
Multicenter StudyPatient-Clinician Communication About End-of-Life Care in Patients With Advanced Chronic Organ Failure During One Year.
Patient-clinician communication is an important prerequisite to delivering high-quality end-of-life care. However, discussions about end-of-life care are uncommon in patients with advanced chronic organ failure. ⋯ End-of-life care communication is poor in patients with chronic organ failure and does not change toward the end of life. Future studies should develop an intervention aiming at initiating high-quality end-of-life care communication between patients with advanced chronic organ failure and their clinicians.